维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="BARRIOS CH"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER-2-negative advanced breast cancer显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1
2	Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence:a threshold and cost-effectiveness analysis显示文摘	Stephen JH Halpern CH Barrios CJ	2012	Addiction2012，107，3：	1
3	The role of capecitabine in early stage breast cane er显示文摘	Barrios CH	2012	Curr Breast Cancer Rep2012，4，1：	1
4	Randomized phase III trial exploring the use of long-actingrelease octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial显示文摘	Hoff PM Saragiotto DF Barrios CH	2014	Clin Oncol2014，32，10：	1
5	Phase II random- ized trial comparing sequential first-line everolimus and second- line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma显示文摘	MOTZER RJ BARRIOS CH KIM TM	2014	J Clin Oncol2014，32，25：	1
6	Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer显示文摘	Blum JL Barrios CH Feldman N	2012	Breast Cancer Res Treat2012，136，3：	1
7	Phase Ⅲ randomized trial of sunitinib versus capecitabine in patients with previously treated HER-2-negative advanced breast cancer 显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1
8	Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer显示文摘	BARRIOS CH LIU MC LEE SC	2010	Breast Cancer Res Treat2010，121，1：	1
9	Phase randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma显示文摘	Motzer RJ Barrios CH Kim TM	2014	J Clin Oncol2014，32，25：	1
10	Breast cancer in Brazil: present status and future goals显示文摘	Lee BL Liedke PE Barrios CH	2012	Lancet Oncol2012，13，3：	1
11	Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer显示文摘	Blum JL Barrios CH Feldman N	2012	Breast Cancer Res Treat2012，136，3：	1
12	REGORD--2: phase II randomized study of everolimus and bevacizumab versus interfer- on a-2a and bevacizumab as first--line therapy in patients with metastatic renal cell carcinoma显示文摘	Ravand A Barrios CH Alekseev B	2015	Ann Oncol2015，26，7：	1
13	1141 POSTER neutropenia and thrombocytopenia during treatment as biomarkers of sunitinib efficacy in patients with metastatic renal cell carcinoma (mRCC)显示文摘	Donskov F Cams A Barrios CH	2011	Eur J Cancer2011，47，1：	1
14	Neutropenia and Thromhocytopenia during treatment as biomarkers of sunitinih efficacy in patients with metastatic renal cell carci- noma显示文摘	Donskov F Carus A Barrios CH	2011	Eur J Cancer2011，47，1：	1
15	Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer 显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1
16	Phase Ⅲ randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1
17	Phase randomizedtrial of sunitinib versus capecitabine in patients with previ-ously treated HER2 - negative advanced breast cancer显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1
18	Pooled analysis ofindividual patient data from capecitabine monotherapyclinical trials in locally advanced or metastatic breastcancer显示文摘	Blum JL Barrios CH Feldman N	2012	Breast Cancer Res Treat2012，136，3：	1
19	Phase m randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1
20	Phase : randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer显示文摘	Barrios CH Liu MC Lee SC	2010	Breast Cancer Res Treat2010，121，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示